|
Latest Pharma Industry News From Medical News Today Headlines:
International Guidelines Will Promote Food Safety Of Plant And Animal Biotech Products
The Biotechnology Industry Organization congratulates the Codex Alimentarius Commission for approving key guidelines to further promote the safety of products from agricultural plant and animal biotechnology. The Codex Commission took final action at its 31st session in Geneva, Switzerland. BIO Applauds U.S. Adoption For GE Corn, Cotton, Soybeans
American farmers have adopted genetically engineered (GE) crops widely since their introduction in 1996, especially corn, cotton and soybean varieties, according to a new USDA report. USDA's Economic Research Service (ERS) report, Adoption of Genetically Engineered Crops in the U.S. was released July 2, 2008. Key findings include: - Adoption of GE soybeans with HT (herbicide-tolerant) traits reached 92 percent in 2008. GE Healthcare's Omnipaque Helpful As Oral Contrast Agent, Technical Note Reports
Low-osmolar contrast media, such as GE Healthcare's Omnipaque (Iohexol), make effective oral contrast agents for abdominal CT scans concluded a technical note written by a team of physicians from Johns Hopkins Medical and published in the March/April 2008 edition of the Journal of Computed Assisted Tomography. "It [Low-osmolar contrast media] is relatively non-absorbable and of low risk to the patient if aspirated," according to the technical note. More Than 500 Backlogged Whistle-Blower Cases Allege Health Care, Drug Company Fraud
Whistle-blower lawsuits alleging that pharmaceutical companies and government contractors defrauded the federal government have created a backlog of more than 900 cases at the Department of Justice, the Washington Post reports. Indian Generic Drug Company Cipla Receives FDA Approval For U.S. Sale Of Antiretroviral Zidovudine
Indian generic pharmaceutical company Cipla recently received full FDA approval to sell and market in the U.S. an oral generic version of the antiretroviral drug zidovudine, the Drug Industry Daily reports. Cipla's application for zidovudine was considered under the expedited review provisions of the | 